A simple, accurate and precise spectroscopic method was developed for simultaneous estimation of Amlodipine besylate and Simvastatin in synthetic mixture using Absorbance correction method. At 360.80 nm (λmax of Amlodipine besylate) Simvastatin has zero absorbance so Amlodipine besylate is directly estimate at 360.80 nm. At 237.60 nm (λmax of Simvastatin) both drugs have some absorbance so Simvastatin is estimate at 237.60 nm using absorbance correction method. The method was found to be linear (r2>0.999) in the range of 5-10 μg/ml for Amlodipine besylate at 360.80 nm. The linear correlation was obtained (r2>0.999) in the range of 5-10 μg/ml for Simvastatin at 237.60 nm. The limit of determination was 0.17 μg/ml and 0.10μg/ml for Amlodipine besylate and Simvastatin, respectively. The limit of quantification was 0. 54μg/ml and 0. 32μg/ml for Amlodipine besylate and Simvastatin, respectively. The accuracy of these method were evaluated by recovery studies and good recovery result were obtained greater than 99%. The method was successfully applied for simultaneous determination of Amlodipine besylate and Simvastatin in binary mixture.
INTRODUCTION
Hypertension (HTN) or high blood pressure, is a very common disorder.Blood pressure is summarised by two measurements, systolic and diastolic, which depend on whether the heart muscle is contracting (systole) or relaxed between beats (diastole). Both the drug used for cholesterol induced hypertension disease. [1] Amlodipine besylate and Simvastatin combination was approved on 28 feb, 2008 [8] A. Amlodipine besylate Amlodipine besylate is long-acting dihydropyridinetype (DHP) calcium channel blocker used to lower blood pressure and to treat anginal chest pain.
A name of Amlodipine besylate is 3-ethyl 5-methyl(4 S)-2-*(2-aminoethoxy)methyl+-4-(2-chlorophenyl)-6-methyl -1 4-dihydropyridine -3 5-dicarboxylate benzene sulphonate. Amlodipine besylate acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, amlodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Simvastatin is HMG-CoA reductase inhibitor(3-hydroxy-3-methylglutaryl-coA Reductase Inhibitor). Simvastatin is used along with a proper diet to help lower "bad"cholesterol and fats (such as LDL, Vol. 3, Issue 6 | magazine.pharmatutor.org triglycerides) and raise "good" cholesterol (HDL) in the blood. Simvastatin used In Hyperlipidaemia Inhibitor of HMG -CoA Reductase Enzyme, HMG-CoA reductase catalyzes the conversion HMG to mevalonate, which is the rate determining step in the biosynthesis of cholesterol, thus inhibition leads to a reduction in the concentration of cholesterol in the liver.
B. Simvastatin
Amlodipine serves as an anti-hypertensive medicine and also increases the lipid-lowering activity of simvastatin through synergistic activity with the lipid-lowering agent. Simvastatin serves as a lipidlowering agent and also has an activity of decreasing blood pressure through a synergistic effect with amlodipine. [8] MATERIALS AND METHODOLOGY [9] -Amlodipine besylate and Simvastatin were obtained as gift samples from Prudence pharmachem, Ankleshwar. And Praveen Laboratories, Surat. Synthetic Mixture contains 10mg of Amlodipine besylate and 10mg of Simvastatin. -A double beam UV/Visible spectrophotometer (Shimadzu model 2450, Japan) with spectral width of 2 nm, 1 cm quartz cells was used to measure absorbance of all the solutions. -Spectra were automatically obtained by UV-Probe system software. -An analytical balance (Sartorius CD2250, Gottingen, Germany) was used for weighing the samples. -Sonicator(D120/2H, TRANS-O-SONIC) -lass 'A' volumetric glassware were used (Borosillicte)
Materials and reagents
Preparation of stock solution of AML Accurately weighed quantity of Amlodipine besylate 10 mg was transferred to 100 ml volumetric flask, dissolved and diluted up to mark with methanol to give a stock solution having strength of 100μg/ml.
Preparation of stock solution of SIM
Accurately weighed quantity of Simvastatin 10mg was transferred to 100 ml volumetric flask, dissolved and diluted up to mark with methanol to give a stock solution having strength of 100μg/ml.
Preparation of Standard Mixture Solution (AML + SIM):
1ml of standard stock solution of AML (100μg/ml) and 1ml of standard stock solution of S M(100μg/ml) were pipetted out into two 10ml volumetric flasks and volume was adjusted to the mark with methanol to get 10μg/ml of AML and 10μg/ml of S M.
Preparation of test solution:
The preparation of synthetic mixture was as per patent: Amlodipine besylate : 10 mg Simvastatin : 10 mg Sodium Starch glycolate: 20 mg Starch : 20 mg Talc : 40 mg All the excipients were mixed in 100ml volumetric flask. make up the volume with Methanol up to 25 ml. and sonicated for 15min .The solution was filtered through Whatman filter paper. and make up the volume up to 100 ml with methanol. Finally the solution had concentration 100μg/ml for Amlodipine besylate and 100μg/ml for Simvastatin.
RESULT AND DISCUSSION SELECTION OF WAVELENGTH AND METHOD DEVELOPMENT FOR DETERMINATION OF AMLODIPINE BESYATE AND SIMVASTATIN
The standard solution of AML and SIM were scanned separately between 200-400nm, and zero-order spectra were not showed overlapping peaks.
-From spectra at 360.80 nm (λmax of Amlodipine besylate) Simvastatin has zero absorbance so Amlodipine besylate is directly estimate at 360.80 nm.
-At 237.60 nm (λmax of Simvastatin) both drugs have some absorbance so Simvastatin is estimate at 237.60 nm using absorbance correction method.
Vol. 3, Issue 6 | magazine.pharmatutor.org [10] Parameters to be considered for the validation of methods are:
VALIDATION OF PROPOSED METHOD

1) LINEARITY AND RANGE Procedure:
The linearity response was determined by analyzing 6 independent levels of calibration curve in the range of 5-10 μg/ml and 5-10 μg/ml for AML and SIM respectively (n=6)
Calibration curve for Amlodipine besylate
This series consisted of five concentrations of standard Amlodipine besylate solution ranging from 5 to 25 μg/ml. The solutions were prepared by pipetting out Standard Amlodipine besylate stock solution (0.5ml, 1ml, 1.5ml, 2.0ml, 2.5ml) was transferred into a series of 10 ml volumetric flask and volume was adjusted up to mark with methanol. A zero order derivative spectrum of the resulting solution was recorded, measured the absorbance at 360.80 nm against a reagent blank solution (methanol). Calibration curve was prepared by plotting absorbance versus respective concentration of Amlodipine besylate.
Calibration curve for Simvastatin
This series consisted of five concentrations of standard Simvastatin solution ranging from 5 to 25 μg/ml. The solutions were prepared by pipetting out Standard Simvastatin stock solution (0.5ml, 1ml, 1.5ml, 2.0ml, 2.5 ml) was transferred into a series of 10 ml volumetric flask and volume was adjusted up to mark with methanol. A zero order derivative spectrum of the resulting solution was recorded, measured the absorbance at 237.60 nm against a reagent blank solution (methanol). Calibration curve was prepared by plotting absorbance versus respective concentration of Simvastatin. 3) ACCURACY -Accuracy of the method was determined by recovery study from synthetic mixture at three levels (80%, 100%, and 120%) of standard addition.
AML
-The % recovery values are tabulated in Table and Percentage recovery for AMLO and SIM by this method was found in the range of 100.37 to 102.12% and 98-101.81% respectively, -The value of %RSD within the limit indicated that the method is accurate and percentage recovery shows that there is no interference from the excipients. Vol. 3, Issue 6 | magazine.pharmatutor.org
4) LOD & LOQ
-The Limit of detection and quantitation of the developed method was assessed by analyzing 10 replicates of standard solutions containing concentrations 5 μg/ml for AML and S M.
-The LOD and LOQ were calculated as LOD = 3.3*σ/S, and LOQ = 10*σ/S, where σ is the standard deviation of the lowest standard concentration and S is the slope of the standard curve.% RSD was calculated. 
CONCLUSION
All the parameters are validated as per ICH guidelines for the method validation and found to be suitable for routine quantitative analysis in pharmaceutical dosage forms. The result of linearity, accuracy, precision proved to be within limits with lower limits of detection and quantification. Ruggedness and Robustness of method was confirmed as no significant were observed on analysis by subjecting the method to slight change in the method condition. Assay results obtained by proposed method are in fair agreement.
